Clincosm LogoSign in Get a demo

Anticoagulants; Increased

Showing 1 - 13 of 13
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Anticoagulants; Increased Trial (catheter induced thromboprophylaxis)

Not yet recruiting
  • Anticoagulants; Increased
  • catheter induced thromboprophylaxis
  • (no location specified)
Jan 21, 2023

Prediction of 30-Day Readmission Using Machine Learning

Not yet recruiting
  • Infection
  • +8 more
    • Boston, Massachusetts
    • +1 more
    Feb 3, 2022

    Infection, Heart Failure, COPD Trial in Boston (Home Hospitalization)

    Recruiting
    • Infection
    • +8 more
    • Home Hospitalization
    • Boston, Massachusetts
    • +1 more
    Sep 15, 2021

    Prediction of Patient Deterioration Using Machine Learning

    Active, not recruiting
    • Infection
    • +8 more
    • Traditional vital sign alarms versus the BioVitals Index vs the National Early Warning Score 2
    • Boston, Massachusetts
    • +1 more
    Sep 15, 2021

    Infection, Heart Failure, COPD Trial in Salt Lake City (Home hospital care)

    Completed
    • Infection
    • +8 more
    • Home hospital care
    • Salt Lake City, Utah
      University of Utah Health
    Jul 6, 2021

    Anticoagulants; Increased Trial (Apixaban)

    Not yet recruiting
    • Anticoagulants; Increased
    • (no location specified)
    May 14, 2021

    Expected Length of Hospital Stay Using Machine Learning

    Active, not recruiting
    • Infection
    • +8 more
      • Boston, Massachusetts
      • +1 more
      Apr 14, 2021

      s in Intensive Care Unit Patients With COVID-19

      Active, not recruiting
      • Covid19
      • +5 more
      • Adjunctive therapies
      • Amsterdam, Netherlands
      • +1 more
      Jan 20, 2021

      Infection, Heart Failure, COPD Trial in Boston (Remote Visit)

      Completed
      • Infection
      • +8 more
      • Remote Visit
      • Boston, Massachusetts
      • +1 more
      Nov 26, 2020

      Anticoagulants; Increased, Left Ventricular Thrombosis Trial in Alexandria (Rivaroxaban 20 MG, Warfarin Sodium)

      Completed
      • Anticoagulants; Increased
      • Left Ventricular Thrombosis
      • Rivaroxaban 20 MG
      • Warfarin Sodium
      • Alexandria, Egypt
        Andalusia Hospitals
      Jun 9, 2020

      Valve Heart Disease, Anticoagulants; Increased Trial in Wuhan (Warfarin Sodium)

      Unknown status
      • Valve Heart Disease
      • Anticoagulants; Increased
      • Warfarin Sodium
      • Wuhan, Hubei, China
        Wuhan Asia Heart Hospital
      Mar 24, 2019

      Infection, Heart Failure, COPD Trial in Boston (Home hospitalization, Traditional inpatient hospitalization)

      Completed
      • Infection
      • +8 more
      • Home hospitalization
      • Traditional inpatient hospitalization
      • Boston, Massachusetts
      • +1 more
      Aug 27, 2018

      Noninvasive Measurement of Blood Coagulation

      Unknown status
      • Anticoagulants; Increased
      • +4 more
      • Measurement of coagulability of blood
      • (no location specified)
      Jul 16, 2017